NEW YORK (GenomeWeb News) – Vermillion today announced the closing of a public offering of stock that raised $17.5 million in net proceeds.

The company offered 9,602,500 shares of common stock at $1.96 per share, including 1,252,500 shares sold pursuant to the underwriters' option to purchase additional shares.

Canaccord Genuity acted as sole book-running manager, and Roth Capital Partners was lead manager for the offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.